Before continuing to this
website, please confirm
that you are a healthcare
professional.

YES
NO

You are now leaving this website The information the reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the respective company, or via the Consumer Medicine Information or Product Information.

Do you want to continue?

YES
Useful resources for you and
your generalised myasthenia gravis
(gMG) patients
Model is not a real patient
Contact UCBCares for further information on gMG

Resources for your clinic

Summary of Scales

Learn more about the different scales used to assess people with myasthenia gravis (MG), including the Myasthenia Gravis Activities of Daily Living (MG-ADL) and Myasthenia Gravis Symptoms Patient-Reported Outcome (MGSPRO) scales.

DOWNLOAD THE SUMMARY OF SCALES BOOKLET

Law et al, 2021. The lived experience of myasthenia gravis: a patient-led analysis

Led by a Patient Council of nine individuals living with MG, this analysis reviewed insights from multiple data sources with the objective of generating a series of statements that best represent the lived experience of gMG. It could be a useful tool for healthcare professionals who interact with MG patients, to help in understanding their daily struggles with the condition.1

READ THE PAPER

Resources for your patients

UCBCares® is a service designed for MG patients and other members of the public who would like to know more about MG. On the UCBCares® website, they can find information about the different types of MG, its symptoms and causes, how it’s diagnosed and treated and how it’s managed.

EXPLORE UCBCARES®
Contact UCBCares for further information on gMG
gMG, generalised myasthenia gravis; MG, myasthenia gravis; MG-ADL, Myasthenia Gravis Activities of Daily Living; MGSPRO, Myasthenia Gravis Symptoms Patient-Reported Outcome.

References

1. Law N, Davio K, Blunck M, et al. The lived experience of myasthenia gravis: a patient-led analysis. Neurol Ther. 2021;10(2):1103–25.